The estimated Net Worth of Capital Management Ii, Llc ... is at least $56.8 Million dollars as of 6 October 2016. Capital Llc owns over 50,000 units of Aimmune Therapeutics Inc stock worth over $47,504,595 and over the last 9 years Capital sold AIMT stock worth over $9,327,400.
Capital has made over 7 trades of the Aimmune Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Capital sold 50,000 units of AIMT stock worth $2,017,000 on 6 October 2016.
The largest trade Capital's ever made was buying 642,035 units of Aimmune Therapeutics Inc stock on 11 August 2015 worth over $10,349,604. On average, Capital trades about 242,503 units every 60 days since 2015. As of 6 October 2016 Capital still owns at least 1,672,697 units of Aimmune Therapeutics Inc stock.
You can see the complete history of Capital Llc stock trades at the bottom of the page.
Over the last 9 years, insiders at Aimmune Therapeutics Inc have traded over $19,285,948 worth of Aimmune Therapeutics Inc stock and bought 61,698,079 units worth $2,225,231,200 . The most active insiders traders include Des Produits Nestle S.A. So..., Patrick G Enright und Des Produits Nestle S.A.Nes.... On average, Aimmune Therapeutics Inc executives and independent directors trade stock every 22 days with the average trade being worth of $21,038,606. The most recent stock trade was executed by Des Produits Nestle S.A. So... on 13 October 2020, trading 54,117,287 units of AIMT stock currently worth $1,867,046,402.
Aimmune Therapeutics Inc executives and other stock owners filed with the SEC include: